Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus

From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients experienced self-limited symptoms after postexposu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Wong, Karen K., Davey, Richard T., Hewlett, Angela L., Kraft, Colleen S., Mehta, Aneesh K., Mulligan, Mark J., Beck, Allison, Dorman, William, Kratochvil, Christopher J., Lai, Lilin, Palmore, Tara N., Rogers, Susan, Smith, Philip W., Suffredini, Anthony F., Wolcott, Mark, Ströher, Ute, Uyeki, Timothy M.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946014/
https://ncbi.nlm.nih.gov/pubmed/27118786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw256
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars